Biomarcadores en espondiloartropatías

Among rheumatic diseases and specifically spondyloarthropathies (SpA), the study of biomarkers, defined as molecules that reflect either biologic or specific pathological process, is an important and necessary area in basic and clinical research, being a consequence or the response of an interventio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: ROMERO-SÁNCHEZ,CONSUELO, LONDOÑO,JOHN, DE AVILA,JULIETTE, VALLE-OÑATE,RAFAEL
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2010
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000900015
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872010000900015
record_format dspace
spelling oai:scielo:S0034-988720100009000152010-11-09Biomarcadores en espondiloartropatíasROMERO-SÁNCHEZ,CONSUELOLONDOÑO,JOHNDE AVILA,JULIETTEVALLE-OÑATE,RAFAEL Biological markers Joint diseases Spondylitis Among rheumatic diseases and specifically spondyloarthropathies (SpA), the study of biomarkers, defined as molecules that reflect either biologic or specific pathological process, is an important and necessary area in basic and clinical research, being a consequence or the response of an intervention. Other markers provide information about the pathogenesis of this disease. Recently, HLA-B27 has been used as diagnostic criteria to detect SpA. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) are clinical scores used to assess disease activity. A new activity index, Ankylosing Spondylitis Disease Activity Score (ASDAS) considers erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as biomarkers. This review describes the state of the art of research on SpA biomarkers. There are promising new candidates as biomarkers such as metallopro-teinase 3, Type II collagen neoepitopes (C2C and C1-2C), C-propeptide of Type II collagen (CPII), aggrecan 846 epitope, macrophage colony stimulating factor, serum amyloid A protein and interleukin-6, among others.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.138 n.9 20102010-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000900015es10.4067/S0034-98872010000900015
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Biological markers
Joint diseases
Spondylitis
spellingShingle Biological markers
Joint diseases
Spondylitis
ROMERO-SÁNCHEZ,CONSUELO
LONDOÑO,JOHN
DE AVILA,JULIETTE
VALLE-OÑATE,RAFAEL
Biomarcadores en espondiloartropatías
description Among rheumatic diseases and specifically spondyloarthropathies (SpA), the study of biomarkers, defined as molecules that reflect either biologic or specific pathological process, is an important and necessary area in basic and clinical research, being a consequence or the response of an intervention. Other markers provide information about the pathogenesis of this disease. Recently, HLA-B27 has been used as diagnostic criteria to detect SpA. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) are clinical scores used to assess disease activity. A new activity index, Ankylosing Spondylitis Disease Activity Score (ASDAS) considers erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as biomarkers. This review describes the state of the art of research on SpA biomarkers. There are promising new candidates as biomarkers such as metallopro-teinase 3, Type II collagen neoepitopes (C2C and C1-2C), C-propeptide of Type II collagen (CPII), aggrecan 846 epitope, macrophage colony stimulating factor, serum amyloid A protein and interleukin-6, among others.
author ROMERO-SÁNCHEZ,CONSUELO
LONDOÑO,JOHN
DE AVILA,JULIETTE
VALLE-OÑATE,RAFAEL
author_facet ROMERO-SÁNCHEZ,CONSUELO
LONDOÑO,JOHN
DE AVILA,JULIETTE
VALLE-OÑATE,RAFAEL
author_sort ROMERO-SÁNCHEZ,CONSUELO
title Biomarcadores en espondiloartropatías
title_short Biomarcadores en espondiloartropatías
title_full Biomarcadores en espondiloartropatías
title_fullStr Biomarcadores en espondiloartropatías
title_full_unstemmed Biomarcadores en espondiloartropatías
title_sort biomarcadores en espondiloartropatías
publisher Sociedad Médica de Santiago
publishDate 2010
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000900015
work_keys_str_mv AT romerosanchezconsuelo biomarcadoresenespondiloartropatias
AT londonojohn biomarcadoresenespondiloartropatias
AT deavilajuliette biomarcadoresenespondiloartropatias
AT valleonaterafael biomarcadoresenespondiloartropatias
_version_ 1718436527128707072